Rho to support NDA for Evoke Pharma’s patented nasal spray

By Melissa Fassbender contact

- Last updated on GMT

Evoke Pharma is a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. (Image: iStock/Mihailgrey)
Evoke Pharma is a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. (Image: iStock/Mihailgrey)

Related tags: New drug application, Pharmacology

Rho has been contracted to support Evoke Pharma’s planned NDA submission for its nasal delivery formulation of metoclopramide, Gimoti.

The regulatory consulting and contract research organization (CRO) will prepare and submit a 505(b)(2) New Drug Application (NDA) for Gimoti, a patented nasal spray for the relief of symptoms associated with acute and recurrent gastroparesis in women with diabetes mellitus.

Rho is a privately-held CRO located in Chapel Hill, NC and provides a range of clinical research services across the drug development process.

"Evoke is very pleased to have Rho on board to assist the Company with the preparation and submission of its planned 505(b)(2) New Drug Application (NDA) for Gimoti​," Dave Gonyer, R.Ph. president and CEO of Evoke Pharma told Outsourcing-Pharma.com.

"The next step for the company is to launch its comparative exposure pharmacokinetic (PK) study for Gimoti which will be conducted by Spaulding Clinical Research and may provide the final data needed for the NDA​," he said.

The Wisconsin-based CRO​ operates a 200-bed clinical pharmacology unit, cardiac core laboratory, and provides biometrics/scientific affairs services.

The PK study is planned for the second half of the year with an NDA submission expected by late 2017 or early 2018.

Related news

Related products

show more

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 17-Jan-2022 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Related suppliers

Follow us

Products

View more

Webinars